0.5062
price up icon5.48%   0.0263
after-market Dopo l'orario di chiusura: .52 0.0138 +2.73%
loading
Precedente Chiudi:
$0.4799
Aprire:
$0.4883
Volume 24 ore:
88,602
Relative Volume:
0.18
Capitalizzazione di mercato:
$27.03M
Reddito:
-
Utile/perdita netta:
$-151.16M
Rapporto P/E:
-0.1704
EPS:
-2.97
Flusso di cassa netto:
$-130.08M
1 W Prestazione:
+8.39%
1M Prestazione:
+10.12%
6M Prestazione:
-68.94%
1 anno Prestazione:
-92.39%
Intervallo 1D:
Value
$0.483
$0.5073
Intervallo di 1 settimana:
Value
$0.444
$0.54
Portata 52W:
Value
$0.404
$6.75

Alx Oncology Holdings Inc Stock (ALXO) Company Profile

Name
Nome
Alx Oncology Holdings Inc
Name
Telefono
650-466-7125
Name
Indirizzo
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Name
Dipendente
65
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
ALXO's Discussions on Twitter

Confronta ALXO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ALXO
Alx Oncology Holdings Inc
0.5062 25.65M 0 -151.16M -130.08M -2.97
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-06 Aggiornamento Jefferies Hold → Buy
2024-12-19 Downgrade Jefferies Buy → Hold
2024-03-08 Downgrade Stifel Buy → Hold
2023-12-08 Aggiornamento Jefferies Hold → Buy
2021-12-22 Downgrade Jefferies Buy → Hold
2021-09-30 Iniziato Stifel Buy
2021-05-05 Ripresa Credit Suisse Outperform
2021-04-26 Ripresa Credit Suisse Outperform
2021-04-06 Iniziato UBS Buy
2021-02-10 Iniziato H.C. Wainwright Buy
2020-08-11 Iniziato Cantor Fitzgerald Overweight
2020-08-11 Iniziato Credit Suisse Outperform
2020-08-11 Iniziato Jefferies Buy
2020-08-11 Iniziato Piper Sandler Overweight
Mostra tutto

Alx Oncology Holdings Inc Borsa (ALXO) Ultime notizie

pulisher
03:08 AM

ALX Oncology Holdings Inc. Stock Analysis and ForecastHigh-yield market plays - Autocar Professional

03:08 AM
pulisher
12:10 PM

Is ALX Oncology Holdings Inc. a good long term investmentMarket-beating returns - jammulinksnews.com

12:10 PM
pulisher
Jul 22, 2025

What analysts say about ALX Oncology Holdings Inc. stockOutstanding risk-reward balance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

What drives ALX Oncology Holdings Inc. stock priceFree Wealth Management Insights - Autocar Professional

Jul 21, 2025
pulisher
Jul 18, 2025

Will ALX Oncology Holdings Inc. stock benefit from interest rate changesConsistent Win Signals - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

How ALX Oncology Holdings Inc. stock performs during market volatilitySwing Trade Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes ALX Oncology Holdings Inc. stock price move sharplyRisk Adjusted Stock Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why ALX Oncology Holdings Inc. stock attracts strong analyst attentionPredictable High Return Trades - Newser

Jul 15, 2025
pulisher
Jul 08, 2025

ALX Oncology (NASDAQ:ALXO) Trading Down 3.5% – What’s Next? - Defense World

Jul 08, 2025
pulisher
Jun 16, 2025

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Jun 16, 2025
pulisher
Jun 12, 2025

ALX Oncology Confirms Directors at Annual Meeting - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

ALX Oncology reports annual meeting results By Investing.com - Investing.com Nigeria

Jun 12, 2025
pulisher
Jun 12, 2025

ALX Oncology reports annual meeting results - Investing.com

Jun 12, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Weighs in on ALX Oncology FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 07, 2025

ALX Oncology (NASDAQ:ALXO) Downgraded to “Sell” Rating by Wall Street Zen - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Nuveen Asset Management LLC Has $275,000 Holdings in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Shares Acquired by Two Sigma Investments LP - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Bank of America Corp DE Grows Position in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Shares Acquired by Deutsche Bank AG - Defense World

Jun 03, 2025
pulisher
May 31, 2025

Northern Trust Corp Acquires 23,324 Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

May 31, 2025
pulisher
May 30, 2025

ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference - GlobeNewswire

May 30, 2025
pulisher
May 30, 2025

ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference | ALXO Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

ALX Oncology Management to Showcase Novel Cancer Treatment Advances at Major Jefferies Healthcare Conference - Stock Titan

May 30, 2025
pulisher
May 27, 2025

D. E. Shaw & Co. Inc. Decreases Stock Position in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World

May 27, 2025
pulisher
May 27, 2025

H.C. Wainwright maintains ALX Oncology stock Buy rating By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

H.C. Wainwright maintains ALX Oncology stock Buy rating - Investing.com

May 27, 2025
pulisher
May 24, 2025

Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and ALX Oncology Holdings (ALXO) - The Globe and Mail

May 24, 2025
pulisher
May 23, 2025

UBS Group Issues Pessimistic Forecast for ALX Oncology (NASDAQ:ALXO) Stock Price - Defense World

May 23, 2025
pulisher
May 22, 2025

Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews

May 22, 2025
pulisher
May 22, 2025

ALX Oncology Holdings Inc. (NASDAQ:ALXO) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World

May 22, 2025

Alx Oncology Holdings Inc Azioni (ALXO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Alx Oncology Holdings Inc Azioni (ALXO) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Pinto Shelly
SVP, FINANCE AND CAO
Jun 30 '25
Sale
0.43
1,532
659
88,820
Pinto Shelly
SVP, FINANCE AND CAO
Feb 19 '25
Sale
1.15
550
633
87,352
Pons Jaume
PRESIDENT & CSO
Feb 19 '25
Sale
1.15
1,326
1,525
579,388
Lettmann Jason
CHIEF EXECUTIVE OFFICER
Feb 19 '25
Sale
1.15
2,159
2,483
170,270
Pinto Shelly
Interim CFO
Jan 06 '25
Sale
1.80
2,221
3,998
87,902
Pinto Shelly
Interim CFO
Dec 30 '24
Sale
1.58
1,426
2,253
90,123
Pons Jaume
PRESIDENT & CSO
Dec 30 '24
Sale
1.58
10,796
17,060
580,714
Hemrajani Rekha
Director
Dec 02 '24
Buy
1.55
30,000
46,404
33,000
Pinto Shelly
SVP, FINANCE AND CAO
Aug 14 '24
Sale
2.58
564
1,455
91,549
Randolph Sophia
CHIEF MEDICAL OFFICER
Aug 14 '24
Sale
2.58
1,365
3,522
325,711
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):